Equity line shares sold
Company: Core Scientific
The claim, verbatim
As of October 26, 2022, Core Scientific had sold 13,354,892 shares under the B. Riley equity line of credit for net proceeds of approximately $20,700,000
Source (primary)
Core Scientific 424B3 filed 2022-10-27 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “As of October 26, 2022, the Company has sold 13,354,892 shares of common stock under B. Riley equity line of credit for net proceeds of approximately $20.7 million.”
How we checked this
Checked on September 22, 2026. The cited source supports every part of this claim.
The document states the share count and net proceeds as of October 26, 2022.
Confirmed in the source:
- As of October 26, 2022, Core Scientific had sold 13,354,892 shares under the B. Riley equity line of credit
- The net proceeds were approximately $20.7 million
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000119312522270429/d395956d424b3.htm) in full (18,255 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific 424B3 filed 2022-10-27
Quote: “As of October 26, 2022, the Company has sold 13,354,892 shares of common stock under B. Riley equity line of credit for net proceeds of approximately $20.7 million.”